Stay updated on Ivosidenib+Venetoclax±Azacitidine in IDH1 Mutated Blood Cancers Clinical Trial

Sign up to get notified when there's something new on the Ivosidenib+Venetoclax±Azacitidine in IDH1 Mutated Blood Cancers Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ivosidenib+Venetoclax±Azacitidine in IDH1 Mutated Blood Cancers Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Difference
    0.1%
    Check dated 2025-11-03T00:58:43.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    41 days ago
    Change Detected
    Summary
    Updated operating status notice and newer versioning information; removed previous revision/date, indicating a shift to current status and version v3.2.0.
    Difference
    11%
    Check dated 2025-10-05T09:21:31.000Z thumbnail image
  5. Check
    49 days ago
    Change Detected
    Summary
    Version updated from v3.0.2 to v3.1.0; no substantive content changes detected.
    Difference
    0.2%
    Check dated 2025-09-28T03:09:54.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    The page now shows a new revision (v3.0.2) dated 2025-09-09, replacing v3.0.1 from 2025-07-30, and adds a '32 2025-09-08 Study Status' entry; the 'Back to Top' link was removed.
    Difference
    2%
    Check dated 2025-09-13T17:16:47.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.
    Difference
    0.6%
    Check dated 2025-09-06T14:47:00.000Z thumbnail image
  8. Check
    77 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of a facility name and location details, while removing specific location terms and listed countries.
    Difference
    34%
    Check dated 2025-08-30T11:34:33.000Z thumbnail image

Stay in the know with updates to Ivosidenib+Venetoclax±Azacitidine in IDH1 Mutated Blood Cancers Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ivosidenib+Venetoclax±Azacitidine in IDH1 Mutated Blood Cancers Clinical Trial page.